China Shineway Pharmaceutical Group (CSWYY) Stock Price, News & Analysis

Company Overview

China Shineway Pharmaceutical Group Ltd. is a Chinese pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicines and related healthcare products. Its portfolio includes prescription and over-the-counter medicines in forms such as injections, capsules, tablets, oral liquids and granules.

The company’s products address a range of therapeutic areas, including respiratory, cardiovascular, digestive and gynecological conditions. Its better-known traditional Chinese medicine products include Qingkailing and Shuanghuanglian formulations, which are marketed in multiple dosage forms.

China Shineway is headquartered in Shijiazhuang, Hebei Province, China, and primarily serves the Chinese pharmaceutical market through hospitals, pharmacies and other healthcare distribution channels. The company has also pursued sales in international markets, although China remains its principal operating geography.

Key Stats

• Today's Range: C$21.49 to C$21.49
• 50-Day Range: C$18.16 to C$21.49
• 52-Week Range: C$18.16 to C$22.23
• Volume: 18 shs
• Average Volume: 829 shs
• Market Capitalization: N/A
• P/E Ratio: 1.26
• Dividend Yield: 20.41%
• Price Target: N/A
• Consensus Rating: N/A

China Shineway Pharmaceutical Group Stock Analysis - MarketRank™

China Shineway Pharmaceutical Group scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for China Shineway Pharmaceutical Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of China Shineway Pharmaceutical Group is 1.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 35.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of China Shineway Pharmaceutical Group is 1.26, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 204.95.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

China Shineway Pharmaceutical Group has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in China Shineway Pharmaceutical Group has recently decreased by 47.46%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

China Shineway Pharmaceutical Group pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

China Shineway Pharmaceutical Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of China Shineway Pharmaceutical Group is 25.79%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

China Shineway Pharmaceutical Group has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for China Shineway Pharmaceutical Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, China Shineway Pharmaceutical Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.01% of the stock of China Shineway Pharmaceutical Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CSWYY
• CIK: N/A
• Web: www.shineway.com.hk
• Phone: 86 31 1880 30066
• Fax: N/A
• Employees: 2,822
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.26
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A